Last reviewed · How we verify

NCT04048499

Prevalence and Severity of Colour Vision Deficiency Among Turkish Children

Completed Last updated 9 August 2019
What this trial tests

trial testing the Colour Assessment and Diagnosis (CAD) test in CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey in 1,374 participants. Completed in 1 March 2019.

Timeline
1 January 2018
Primary endpoint
1 March 2019
1 March 2019

Quick facts

Lead sponsorMedipol University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,374
Start date1 January 2018
Primary completion1 March 2019
Estimated completion1 March 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 6 to 18, any sex, with CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the usability of the Colour Assessment and Diagnosis (CAD) test in children. To determine the prevalence of colour vision deficiency (CVD) among Turkish children, to identify the class of deficiency and to quanify severity of loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04048499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing